X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15177) 15177
Book Review (1723) 1723
Publication (1311) 1311
Newspaper Article (352) 352
Book / eBook (172) 172
Trade Publication Article (48) 48
Magazine Article (32) 32
Conference Proceeding (27) 27
Book Chapter (25) 25
Government Document (17) 17
Newsletter (9) 9
Dissertation (8) 8
Reference (6) 6
Web Resource (4) 4
Data Set (3) 3
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13951) 13951
animals (10873) 10873
male (8727) 8727
narcotic antagonists - pharmacology (6653) 6653
rats (6285) 6285
pharmacology & pharmacy (4797) 4797
humans (4742) 4742
neurosciences (4218) 4218
naloxone - pharmacology (3882) 3882
mice (3473) 3473
morphine (3186) 3186
female (3114) 3114
dose-response relationship, drug (3011) 3011
narcotics (2999) 2999
morphine - pharmacology (2694) 2694
rats, sprague-dawley (2474) 2474
naltrexone - pharmacology (2435) 2435
narcotics - pharmacology (2431) 2431
naloxone (1969) 1969
pain (1739) 1739
naltrexone - analogs & derivatives (1606) 1606
analgesics, opioid - pharmacology (1567) 1567
opioids (1561) 1561
psychiatry (1471) 1471
rats, wistar (1406) 1406
adult (1382) 1382
analgesia (1354) 1354
naltrexone (1254) 1254
time factors (1253) 1253
rat (1197) 1197
narcotic antagonists - therapeutic use (1196) 1196
pharmacology (1150) 1150
analgesics (1140) 1140
brain (1140) 1140
opioid receptors (1122) 1122
receptors (1097) 1097
narcotic antagonists (1094) 1094
narcotic antagonists - administration & dosage (1090) 1090
behavior, animal - drug effects (1047) 1047
drug interactions (985) 985
rodents (970) 970
receptors, opioid - drug effects (927) 927
analgesics - pharmacology (925) 925
receptors, opioid - metabolism (910) 910
analgesics, non-narcotic - pharmacology (898) 898
in vitro techniques (878) 878
article (849) 849
drug abuse (849) 849
research (806) 806
middle aged (797) 797
pain - drug therapy (787) 787
opioid (779) 779
disease models, animal (778) 778
substance abuse (770) 770
analysis (769) 769
motor activity - drug effects (762) 762
receptors, opioid, mu - metabolism (746) 746
cocaine (730) 730
antinociception (713) 713
biochemistry & molecular biology (712) 712
neurons (711) 711
drugs (705) 705
dopamine (702) 702
nucleus-accumbens (700) 700
receptors, opioid - physiology (695) 695
behavioral sciences (690) 690
dependence (671) 671
analysis of variance (663) 663
clinical neurology (656) 656
receptors, opioid, mu - antagonists & inhibitors (653) 653
addiction (649) 649
beta-endorphin (649) 649
morphine - administration & dosage (640) 640
pain measurement - drug effects (628) 628
anesthesiology (612) 612
care and treatment (604) 604
tolerance (600) 600
brain - metabolism (599) 599
injections, intraventricular (599) 599
drug tolerance (598) 598
medicine (591) 591
abridged index medicus (580) 580
buprenorphine (577) 577
pain measurement (569) 569
physiology (565) 565
brain - drug effects (563) 563
heroin (557) 557
receptors, opioid, mu - agonists (555) 555
neurons - drug effects (553) 553
analgesics, opioid - administration & dosage (552) 552
expression (546) 546
reward (540) 540
inhibition (539) 539
rats, inbred strains (531) 531
naloxone - administration & dosage (529) 529
ligands (517) 517
activation (516) 516
guinea pigs (516) 516
naltrexone - therapeutic use (507) 507
naltrexone - administration & dosage (505) 505
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (87) 87
Robarts - Stacks (49) 49
UofT at Mississauga - Stacks (18) 18
UTL at Downsview - May be requested (14) 14
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Criminology - Stacks (7) 7
Online Resources - Online (6) 6
UofT at Scarborough - Stacks (6) 6
OISE - Stacks (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (4) 4
Law (Bora Laskin) - Stacks (3) 3
Gerstein Science - Reference (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Gerstein Science - Periodical Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
New College (Ivey) - Reserve desk (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Storage (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15546) 15546
Russian (125) 125
French (39) 39
German (36) 36
Chinese (24) 24
Japanese (23) 23
Spanish (12) 12
Italian (10) 10
Polish (7) 7
Dutch (4) 4
Hungarian (4) 4
Ukrainian (3) 3
Bulgarian (2) 2
Finnish (2) 2
Arabic (1) 1
Czech (1) 1
Danish (1) 1
Korean (1) 1
Lithuanian (1) 1
Romanian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1964, American lecture series, publication no. 598. A monograph in American lectures in anesthesiology, 425
Book
Nature, ISSN 0028-0836, 2014, Volume 506, Issue 7487, pp. 191 - 196
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2016, Volume 173, Issue 5, pp. 856 - 869
Journal Article
Journal Article
Obesity, ISSN 1930-7381, 05/2013, Volume 21, Issue 5, pp. 935 - 943
Objective: To examine the effects of naltrexone/bupropion (NB) combination therapy on weight and weight-related risk factors in overweight and obese... 
NUTRITION & DIETETICS | METAANALYSIS | OVERWEIGHT | ENDOCRINOLOGY & METABOLISM | ADULTS | HYPERTENSION | BLOOD-PRESSURE | LIFE | Naltrexone - therapeutic use | Dopamine Uptake Inhibitors - adverse effects | Dyslipidemias - complications | Obesity - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Dopamine Uptake Inhibitors - therapeutic use | Anti-Obesity Agents - adverse effects | Male | Weight Loss - drug effects | Anti-Obesity Agents - therapeutic use | Overweight | Naltrexone - pharmacology | Adult | Female | Drug Therapy, Combination | Bupropion - adverse effects | Bupropion - therapeutic use | Cardiovascular Diseases - etiology | Dopamine Uptake Inhibitors - pharmacology | Double-Blind Method | Obesity - complications | Risk Factors | Narcotic Antagonists - adverse effects | Feeding Behavior - drug effects | Nausea - etiology | Narcotic Antagonists - therapeutic use | Narcotic Antagonists - pharmacology | Obesity - prevention & control | Hypertension - complications | Quality of Life | Bupropion - pharmacology | Naltrexone - adverse effects | Anti-Obesity Agents - pharmacology | Delayed-Action Preparations | Hypertension | Studies | Obesity | Medical research | Nutrition research | Weight control | Behavior | Diabetes | Drug dosages | Food | Quality of life | Index Medicus | Clinical Trials | Behavior, Pharmacotherapy, Devices, Surgery
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 04/2003, Volume 305, Issue 1, pp. 323 - 330
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 905 - 915
Mu-opioid and CB1-cannabinoid agonists produce analgesia; however, adverse effects limit use of drugs in both classes. Additive or synergistic effects... 
Analgesia | Morphine | Marijuana | G-protein | Adenylyl cyclase | CB1 receptors | AGONIST MORPHINE | ACTIVATION | PROTEIN-KINASE | CB1 CANNABINOID RECEPTOR | SYNERGISTIC INTERACTIONS | NEUROSCIENCES | INHIBITION | KAPPA | FULL AGONIST | ADENYLYL-CYCLASE | PHARMACOLOGY & PHARMACY | RAT-BRAIN | Pyrazoles - therapeutic use | Receptor, Cannabinoid, CB2 - agonists | Humans | Analgesics, Opioid - pharmacology | Receptors, Opioid, mu - agonists | Piperidines - pharmacology | Cannabinoid Receptor Agonists - therapeutic use | Recombinant Proteins - antagonists & inhibitors | Piperidines - metabolism | Receptors, Opioid, mu - metabolism | Morpholines - metabolism | Analgesics, Non-Narcotic - metabolism | Drug Inverse Agonism | Mice | Analgesics, Opioid - metabolism | Kinetics | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Analgesics, Opioid - antagonists & inhibitors | Cannabinoid Receptor Agonists - metabolism | Cricetulus | Analgesics, Non-Narcotic - pharmacology | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB2 - genetics | Analgesics, Opioid - adverse effects | Narcotic Antagonists - metabolism | Receptor, Cannabinoid, CB1 - agonists | Analgesics, Non-Narcotic - adverse effects | Cannabinoid Receptor Agonists - adverse effects | Morpholines - adverse effects | CHO Cells | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Binding, Competitive | Recombinant Proteins - metabolism | Cricetinae | Morpholines - pharmacology | Narcotic Antagonists - adverse effects | Recombinant Proteins - agonists | Analgesics, Non-Narcotic - therapeutic use | Pyrazoles - metabolism | Mice, Inbred Strains | Receptors, Opioid, mu - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Narcotic Antagonists - pharmacology | Piperidines - adverse effects | Receptors, Opioid, mu - genetics | Index Medicus | Drugs | Pain perception | Opioid receptors | Cyclic AMP | Opioid receptors (type mu) | Antagonists | Cannabinoid CB1 receptors | Guanine nucleotide-binding protein | Antagonism | Cell activation | Side effects | Inverse agonists | CB1 Receptors | Adenylyl Cyclase
Journal Article
Circulation Research: Journal of the American Heart Association, ISSN 0009-7330, 04/2004, Volume 94, Issue 7, pp. 960 - 966
ABSTRACT—Glycogen synthase kinase (GSK) inhibition produced by ischemic preconditioning has been previously shown to be regulated through... 
Phosphatidylinositol-3 kinase | Reperfusion | Glycogen synthase kinase | Target of rapamycin | Opioids | LOCALIZATION | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTECTION | PHOSPHORYLATION | phosphatidylinositol-3 kinase | PHOSPHATIDYLINOSITOL 3-KINASE | CELL-SURVIVAL | KINASE-3-BETA | INSULIN | P70S6 KINASE | INDUCED DELAYED CARDIOPROTECTION | glycogen synthase kinase | PERIPHERAL VASCULAR DISEASE | target of rapamycin | HEMATOLOGY | reperfusion | opioids | Glycogen Synthase Kinase 3 - physiology | Maleimides - pharmacology | Receptors, Retinoic Acid - physiology | Glycogen Synthase Kinase 3 beta | Male | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Receptors, Thyroid Hormone - antagonists & inhibitors | Aminophenols - pharmacology | Cardiotonic Agents - therapeutic use | Myocardial Infarction - pathology | Indoles - pharmacology | Benzamides - pharmacology | Chromones - pharmacology | Nuclear Receptor Subfamily 1, Group F, Member 3 | Morphine - pharmacology | Glycogen Synthase Kinase 3 - antagonists & inhibitors | Morpholines - pharmacology | Rats | Receptors, Retinoic Acid - antagonists & inhibitors | Cardiotonic Agents - pharmacology | Myocardial Infarction - metabolism | Receptors, Opioid, delta - drug effects | Piperazines - pharmacology | Rats, Sprague-Dawley | Receptors, Thyroid Hormone - physiology | Sirolimus - pharmacology | Animals | Androstadienes - pharmacology | Signal Transduction - drug effects | Narcotic Antagonists - pharmacology | Phosphatidylinositol 3-Kinases - physiology | Premedication | Index Medicus
Journal Article
Journal Article
Nature Medicine, ISSN 1078-8956, 01/2007, Volume 13, Issue 1, pp. 35 - 37
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that... 
MEDICINE, RESEARCH & EXPERIMENTAL | VISCERAL PAIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | NCFM | RATS | COLON INFLAMMATION | EXPRESSION | IRRITABLE-BOWEL-SYNDROME | HYPERSENSITIVITY | CELL BIOLOGY | Intestines - drug effects | Probiotics - administration & dosage | Abdominal Pain - prevention & control | Narcotic Antagonists - administration & dosage | Receptor, Cannabinoid, CB2 - physiology | Cannabinoid Receptor Antagonists | Humans | Colon - drug effects | Receptors, Cannabinoid - physiology | Analgesics, Opioid - pharmacology | Male | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Receptor, Cannabinoid, CB2 - biosynthesis | Indoles - administration & dosage | Receptors, Opioid, mu - biosynthesis | Dose-Response Relationship, Drug | Receptors, Opioid - physiology | Rectum - drug effects | Colon - physiopathology | Indoles - pharmacology | Receptors, Cannabinoid - biosynthesis | Rectum - microbiology | Morphine - pharmacology | Administration, Oral | Lactobacillus acidophilus - physiology | Abdominal Pain - physiopathology | Rats | Probiotics - pharmacology | Receptors, Opioid, mu - antagonists & inhibitors | Rats, Sprague-Dawley | HT29 Cells | Animals | Intestines - microbiology | Rectum - physiopathology | Analgesics, Opioid - administration & dosage | Naloxone - pharmacology | Narcotic Antagonists - pharmacology | Receptors, Opioid - biosynthesis | Colon - microbiology | Mice | Mice, Inbred BALB C | Intestines - physiopathology | Naloxone - administration & dosage | Morphine - administration & dosage | Receptors, Opioid, mu - physiology | Bacteria | Pain | Microbiology | Gastrointestinal diseases | Irritable bowel syndrome | Index Medicus
Journal Article
Neuropharmacology, ISSN 0028-3908, 02/2014, Volume 77, pp. 131 - 144
Journal Article